Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
Learn more
BIO Statement on Reintroduction of the PASTEUR Act
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Biotechnology Innovation Organization and Biominas Brasil to Co-Host BIO Latin America Conference
August 3, 2016
Meeting will bring together biotechnology executives, academics and investors from around the globe 
New PBS Film and 2016 BIO Animal Biotech Summit Highlight Biotech Solutions to Combating Emerging Infectious Diseases
August 1, 2016
Programming at this year’s Animal Biotech Summit, Advancing One Health through Biotechnology, will look at how biotechnology can be used in emerging infectious disease surveillance and rapid diagnosis, while highlighting the flexibility…
Pennsylvania Governor Wolf Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines
July 22, 2016
BIO and Pennsylvania Bio commend Governor Tom Wolf for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physicians.
BIO Statement on Prescription Drug User Fee Act Goals Letter
July 15, 2016
Washington, D.C. (July 15, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement today regarding the Prescription Drug User Fee Act (PDUFA) VI goals letter:
BIO and Nikon Instruments Inc. Jointly announce a new Program for Research Grade Microscope System for BIO Members
July 15, 2016
BIO and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions® offerings.
BIO Applauds Advancement of H.R. 3299
July 14, 2016
Statement on House Energy & Commerce Committee Passage of H.R. 3299, the Strengthening Public Health Emergency Response Act of 2016
BIO Applauds Passage of Federal Approach to GMO Disclosure
July 14, 2016
Washington, D.C. (July 14, 2016) – The Biotechnology Innovation Organization (BIO) welcomes Congressional passage of a federal, uniform approach to GMO disclosure.  
BIO Submits Comments on Proposed 2017 Renewable Fuel Standards
July 11, 2016
BIO today submitted comments on EPA's proposed Renewable Fuel Standards for 2017, demonstrating that EPA’s interpretation of statutory waiver authority is flawed and its proposed volumes of renewable fuel available for the program are too low and…
BIO Congratulates Senate on Passage of GMO Disclosure Package
July 8, 2016
BIO applauds and commends the U.S. Senate for approving the bipartisan Roberts-Stabenow GMO labeling and disclosure solution.
BIO Applauds Senate Support of GMO Disclosure Package
July 7, 2016
Food and ag groups urge Senate passage this weekWashington, D.C. (July 7, 2016) – The Biotechnology Innovation Organization (BIO) joins more than a thousand food and agriculture organizations from across the country in applauding action in the U.S…